Deborah Ascheim - Net Worth and Insider Trading

Deborah Ascheim Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Deborah Ascheim owns 1 companies in total, including Capricor Therapeutics Inc (CAPR) .

Click here to see the complete history of Deborah Ascheim’s form 4 insider trades.

Insider Ownership Summary of Deborah Ascheim

Ticker	Comapny	Transaction Date	Type of Owner
CAPR	Capricor Therapeutics Inc	2015-08-03	Chief Medical Officer

Deborah Ascheim Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Deborah Ascheim Ownership Network

Ownership Network List of Deborah Ascheim

No Data

Ownership Network Relation of Deborah Ascheim

Deborah Ascheim Owned Company Details

What does Capricor Therapeutics Inc do?

Who are the key executives at Capricor Therapeutics Inc?

Deborah Ascheim is the Chief Medical Officer of Capricor Therapeutics Inc. Other key executives at Capricor Therapeutics Inc include CHIEF BUSINESS OFFICER Xavier Avat , director & CHIEF EXECUTIVE OFFICER Linda Marban , and EVP & GENERAL COUNSEL Karen Krasney .

Capricor Therapeutics Inc (CAPR) Insider Trades Summary

Over the past 18 months, Deborah Ascheim made no insider transaction in Capricor Therapeutics Inc (CAPR). Other recent insider transactions involving Capricor Therapeutics Inc (CAPR) include a net purchase of 7,993 shares made by David B Musket , a net purchase of 2,798,507 shares made by , and a net purchase of 10,000 shares made by Collier Earl M Jr .

In summary, during the past 3 months, insiders sold 0 shares of Capricor Therapeutics Inc (CAPR) in total and bought 2,798,507 shares, with a net purchase of 2,798,507 shares. During the past 18 months, 0 shares of Capricor Therapeutics Inc (CAPR) were sold and 2,821,500 shares were bought by its insiders, resulting in a net purchase of 2,821,500 shares.

Capricor Therapeutics Inc (CAPR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Capricor Therapeutics Inc Insider Transactions

No Available Data

Deborah Ascheim Mailing Address

Above is the net worth, insider trading, and ownership report for Deborah Ascheim. You might contact Deborah Ascheim via mailing address: C/o Capricor, Inc., 8840 Wilshire Blvd, 2nd Floor, Beverly Hills Ca 90211.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.